Eli Lilly cautious on using FDA fast-track voucher for weight loss pill

(Reuters) -Eli Lilly’s international president Patrik Jonsson said on Wednesday the company had little clarity on the U.S. Food and Drug Administration’s new fast-track review process, cautioning it was too early to assume the firm would use it for its experimental weight-loss pill orforglipron. “There is very little knowledge about this national priority voucher today. I would not assume we will submit with a national priority voucher, because we do not fully understand what it contains,” Jonsson told Reuters in an interview.

(Reporting by Maggie Fick and Mrinalika Roy. Editing by Mark Potter)